| 2024年中报 | 2023年年报 | 2023年中报 | 2022年年报 | 2022年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 疫苗分部(元) | 525,603,747.32 | - | 3,387,077,070.32 | - | 4,363,385,481.71 |
| 诊断分部(元) | 826,900,057.38 | - | 762,995,761.68 | - | 1,559,881,638.34 |
| 体外诊断(元) | - | 1,533,354,630.91 | - | 2,674,115,626.59 | - |
| 疫苗(元) | - | 3,960,126,056.91 | - | 8,492,556,779.84 | - |
| 营业成本(元) | |||||
| 疫苗分部(元) | 157,586,097.82 | - | - | - | - |
| 诊断分部(元) | 202,594,089.02 | - | - | - | - |
| 体外诊断(元) | - | 454,296,564.09 | - | 646,114,475.68 | - |
| 疫苗(元) | - | 332,564,649.09 | - | 518,537,306.07 | - |
| 毛利(元) | |||||
| 疫苗分部(元) | 368,017,649.50 | - | - | - | - |
| 诊断分部(元) | 624,305,968.36 | - | - | - | - |
| 体外诊断(元) | - | 1,079,058,066.82 | - | 2,028,001,150.91 | - |
| 疫苗(元) | - | 3,627,561,407.82 | - | 7,974,019,473.77 | - |
| 毛利率(%) | |||||
| 疫苗分部(%) | 70.02 | - | - | - | - |
| 诊断分部(%) | 75.50 | - | - | - | - |
| 体外诊断(%) | - | 70.37 | - | 75.84 | - |
| 疫苗(%) | - | 91.60 | - | 93.89 | - |
| 收入构成(%) | |||||
| 疫苗分部(%) | 38.86 | - | 81.61 | - | 73.67 |
| 诊断分部(%) | 61.14 | - | 18.39 | - | 26.33 |
| 体外诊断(%) | - | 27.91 | - | 23.95 | - |
| 疫苗(%) | - | 72.09 | - | 76.05 | - |
| 毛利构成(%) | |||||
| 疫苗分部(%) | 37.09 | - | - | - | - |
| 诊断分部(%) | 62.91 | - | - | - | - |
| 体外诊断(%) | - | 22.93 | - | 20.28 | - |
| 疫苗(%) | - | 77.07 | - | 79.72 | - |